Compounds, compositions, and methods for selectively inhibiting β-glucuronidases and alleviating side effects associated with drug treatment induced diarrhea

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12017994
APP PUB NO 20210094917A1
SERIAL NO

16959491

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure describes compounds and compositions that inhibit β-glucuronidase activity, and methods for attenuating the side effects of one or more drugs and improving the efficacy of drugs by administration of selective β-glucuronidase inhibitors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SYMBERIX INC4819 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Peterson, Ward Morrisville, US 4 0
Tavares, Francis X Durham, US 30 442
Wallace, Bret D Durham, US 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 25, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 25, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 25, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00